January 6, 2021
PENTICTON, BC, January 6, 2021 – EastWest Bioscience Inc. (“EastWest” or the “Corporation“) announces that the Corporation has appointed Ciska Asriel to serve as interim Chief […]
January 4, 2021
VANCOUVER, BC, January 4, 2021 – EastWest Bioscience Inc. (“EastWest” or the “Corporation“) provides this default announcement indicating EastWest’s failure to file its interim financial statements […]
December 29, 2020
VANCOUVER, BC / ACCESSWIRE / December 29, 2020 / Eastwest Bioscience Inc. (“Eastwest” or the “Corporation“) announces that it filed its annual consolidated financial statements for the […]
December 14, 2020
VANCOUVER, BC / ACCESSWIRE / December 14, 2020 / Eastwest Bioscience Inc. (TSXV:EAST)(“Eastwest” or the “Corporation“) provides this bi-weekly default status report in accordance with National Policy […]
December 1, 2020
VANCOUVER, BC / ACCESSWIRE / December 1, 2020 / Eastwest Bioscience Inc. (“Eastwest” or the “Corporation“) provides this default announcement indicating Eastwest’s anticipated failure to file its […]
November 17, 2020
VANCOUVER, BC / ACCESSWIRE / November 17, 2020 / EastWest Bioscience Inc. (the “Company” or “EastWest“) (TSXV:EAST) announces the issuance of 613,467 common shares at a price of CDN […]
October 22, 2020
Penticton, BC / October 21, 2020 / EastWest Bioscience (the “Company” or “EastWest”) (TSX.V: EAST) EastWest is pleased to announce the appointment of Carlo Bevilacqua as […]
July 23, 2020
PENTICTON, BC / ACCESSWIRE / July 23, 2020 / EastWest Bioscience (the “Company” or “EastWest“) (TSXV:EAST) reports that, on July 8, 2020, the US Securities and Exchange […]
June 30, 2020
Key highlights of third quarter of 2020 fiscal year Total expenses for the three months ended were $520,274 as compared to $1,158,648 for the same period […]